Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective

1. Dimitrescu Al.,Trifu P. (1992) Precancerele SiCancerele Cutanate Vol I Pag 9-26,149-185., Ed. Medicala, Bucuresti.Search in Google Scholar

2. Green A, Battistutad,Hart V .S (1996). Cancer In A Subtropical Australian Population. Thenambour Study Group. Am J Epidemiol; 144:1034-1040.10.1093/oxfordjournals.aje.a008875Search in Google Scholar

3. Morarul (1980). Anatomiepatologică vol II. Ed. Medicala, Bucuresti.Search in Google Scholar

4. Rahbari H, Mehregan Ah. (1982) Basal Cell Epithelioma (Carcinoma) In Children And Teenagers. Cancer ;49:350-363.10.1002/1097-0142(19820115)49:2<350::AID-CNCR2820490223>3.0.CO;2-YSearch in Google Scholar

5. Ji R C. (2006) Lymphatic Endothelial Cells, Lymphangiogenesis, And Extracellular Matrix. Lymphat Res Biol. ;4(2):83-100.10.1089/lrb.2006.4.83Search in Google Scholar

6. Cruse P.J.E., Mcphedran N.T. (1987) Wound Healing Andmanagement. In:„Sabiston’sTextbook Of Surgery”, Editia A 14-A. W. B. Saunders Company, Philadelphia : 117-121.Search in Google Scholar

7. Walling Hw, Fosko Sw, Geraminejad Pa, Whitaker Dc, Arpey Cj. (2004) Aggressive Basal Cell Carcinoma: Presentation, Pathogenesis, And Management. Cancer Metastasis Rev. ;23(3-4):389-402.10.1023/B:CANC.0000031775.04618.30Search in Google Scholar

8. Scanlan D, Radio Sj, Nelson M, Zhou M, Streblow R, Prasad V, Reyes C, Perry D, Fletcher S, Bridge Ja. (2008) Loss Of The Ptch1 Gene Locus In Cardiac Fibroma.Cardiovascpathol.17(2):93-7.10.1016/j.carpath.2007.08.001Search in Google Scholar

9. Weiss Gj, Korn Rl. (2012) Metastatic Basal Cell Carcinoma In The Era Of Hedgehog Signaling Pathway Inhibitors.Cancer.10.1002/cncr.27532Search in Google Scholar

10. Ting Pt, Kasper R, Arlette Jp. (2005)Metastatic Basal Cell Carcinoma: Report Of Two Cases And Literature Review. J Cutan Med Surg. (1):10-5.10.1177/120347540500900104Search in Google Scholar

11. Young Lc, Listgarten J, Trotter Mj, Andrew Se, Tron Va. (2008) Evidence That Dysregulated Dna Mismatch Repair Characterizes Human Nonmelanoma Skin Cancer. Br J Dermatol. 158(1):59-69.Search in Google Scholar

12. Howell Bg, Solish N, Lu C, Watanabe H, Mamelak Aj, Freed I, Wang B, Sauder Dn. (2005) Microarray Profiles Of Human Basal Cell Carcinoma: Insights Into Tumor Growth And Behavior. J Dermatol Sci.39(1):39-51. Epub 2005 Apr 18.10.1016/j.jdermsci.2005.02.004Search in Google Scholar

13. Zhang M, Liang L, Morar N, Dixon Al, Lathrop Gm, Ding J, Moffatt Mf, Cookson Wo, Kraft P, Qureshi Aa, Han J. (2012) Integrating Pathway Analysis And Genetics Of Gene Expression For Genome-Wide Association Study Of Basal Cell Carcinoma. Hum Genet.;131(4):615-23.10.1007/s00439-011-1107-5Search in Google Scholar

14. Bale Ae, Yu Kp. (2001) The Hedgehog Pathway And Basal Cell Carcinomas. Hum Mol Genet. 10(7):757-62.10.1093/hmg/10.7.757Search in Google Scholar

15. Wicking C, Mcglinn E. (2001) The Role Of Hedgehog Signalling In Tumorigenesis.Cancer Lett.173(1):1-7.10.1016/S0304-3835(01)00676-0Search in Google Scholar

16. Zhang H, Ping Xl, Lee Pk, Wu Xl, Yao Yj, Zhang Mj, Et Al.(2001) Role Of Ptch And P53 Genes In Early-Onset Basal Cell Carcinoma. Am J Pathol. 158(2):381-5.10.1016/S0002-9440(10)63980-6Search in Google Scholar

17. Weinstein Mc, Brodell Rt, Bordeaux J, Honda K. (2012) The Art And Science Of Surgical Margins For The Dermatopathologist.Am JDermatopathol. 34(7):737-45.10.1097/DAD.0b013e31823347cbSearch in Google Scholar

18. Ferrandiz L, Ruiz-De-Casas A, Trakatelli M, De Vries E, Ulrich M, Aquilina S, Saksela O, Majewski S, Ranki A, Proby C, Magnoni C, Pitkänen S, Kalokasidis K, Siskou S, Hinrichs B, Altsitsiadis E, Stockfleth E, Moreno-Ramirez D; Epiderm Group. (2012) Assessing Physicians’ Preferences On Skin Cancer Treatment In Europe.Br J Dermatol. 67suppl 2:29-35.10.1111/j.1365-2133.2012.11084.xSearch in Google Scholar

19. Messeguer F, Serra-Guillen C, Echeverria B, Requena C, Sanmartin O, Llombart B, Guillen C, Nagore E. (2012) A Pilot Study Of Clinical Efficacy Of Imiquimod And Cryotherapy For The Treatment Of Basal Cell Carcinoma With Incomplete Response To Imiquimod.JEuracaddermatolvenereol. ;26(7):879-81.10.1111/j.1468-3083.2011.04177.xSearch in Google Scholar

20. Olschewski T, Bajor K, Lang B, Lang E, Seegenschmiedt Mh. (2006) Radiotherapy Of Basal Cell Carcinoma Of The Face And Head: Importance Of Low Dose Per Fraction On Long- Term Outcome. J Dtschdermatolges. 4(2):124-30.10.1111/j.1610-0387.2006.05880.xSearch in Google Scholar

21. Mendenhall Wm, Amdur Rj, Hinerman Rw, Cognetta Ab, Mendenhall Np. (2009) Radiotherapy For Cutaneous Squamous And Basal Cell Carcinomas Of The Head And Neck. Laryngoscope. 119(10):1994-910.1002/lary.20608Search in Google Scholar

22. De Vijlder Hc, Sterenborg Hj, Neumann Ha, Robinson Dj, De Haas Er. (2012) Light Fractionation Significantly Improves The Response Of Superficial Basal Cell Carcinoma To Aminolaevulinic Acid Photodynamic Therapy: Five-Year Follow-Up Of A Randomized, Prospective Trial. Acta Derm Venereol. 17;92(6):641-7.10.2340/00015555-1448Search in Google Scholar

23. Puccioni M, Santoro N, Giansanti F, Ucci F, Rossi R, Lotti T, Et Al. (2009) Photodynamic Therapy Using Methyl Aminolevulinate Acid In Eyelid Basal Cell Carcinoma: A 5-Year Follow-Up Study. Ophthalplastreconstr Surg.;25(2):115-810.1097/IOP.0b013e31819a4404Search in Google Scholar

24. Moore Ay. (2009) Clinical Applications For Topical 5-Fluorouracil In The Treatment Of Dermatological Disorders.J Dermatolog Treat. 20(6):328-35.10.3109/09546630902789326Search in Google Scholar

25. Miller Bh, Shavin Js, Cognetta A, Taylor Rj, Salasche S, Korey A, Et Al. (1997) Nonsurgical Treatment Of Basal Cell Carcinomas With Intralesional 5-Fluorouracil/Epinephrine Injectable Gel. J Am Acad Dermatol.36(1):72-710.1016/S0190-9622(97)70328-1Search in Google Scholar

26. Drehs Mm, Cook-Bolden F, Tanzi El, Weinberg Jm. (2002) Successful Treatment Of Multiple Superficial Basal Cell Carcinomas With Topical Imiquimod: Case Report And Review Of The Literature. Dermatol Surg. 28(5):427-910.1046/j.1524-4725.2002.01231.xSearch in Google Scholar

27. Tandon Y, Brodell Rt. (2012) Local Reactions To Imiquimod In The Treatment Of Basal Cell Carcinoma. Dermatol Online J. 15;18(9):1.10.5070/D36DM013FJSearch in Google Scholar

28. Van Der Geer S, Martens J, Van Roij J, Brand E, Ostertag Ju, Verhaegh Me, Neumann Ha, Krekels Ga. (2012) Imiquimod 5% Cream As Pretreatment Of Mohs Micrographic Surgery For Nodular Basal Cell Carcinoma In The Face: A Prospective Randomized Controlled Study. BrJ Dermatol. 67(1):110-5.10.1111/j.1365-2133.2012.10924.x22385074Search in Google Scholar

29. So Pl, Fujimoto Ma, Epstein Eh Jr. (2008) Pharmacologic Retinoid Signaling And Physiologic Retinoic Acid Receptor Signaling Inhibit Basal Cell Carcinoma Tumorigenesis. Mol Cancer Ther. 7(5):1275-8410.1158/1535-7163.MCT-07-2043Search in Google Scholar

30. Bianchi L, Orlandi A, Campione E, Angeloni C, Costanzo A, Spagnoli Lg, Chimenti S. (2004) Topical Treatment Of Basal Cell Carcinoma With Tazarotene: A Clinicopathological Study On A Large Series Of Cases. Br J Dermatol. 151(1):148-5610.1111/j.1365-2133.2004.06044.x15270884Search in Google Scholar